Reliance Global Group, Inc. (EZRA): debt financing — Reliance Global Group invests $2M in Innervate Radiopharmaceuticals via LifeSci Global biotech arm

Reliance Global Group, Inc.

LifeSci Global (51% owned by Reliance) agrees to acquire 421,053 Innervate units at $4.75/unit for $2M total; $500K funded at closing.
Innervate develops 18F-mFBG PET imaging for neuroblastoma; initial market ~$250M with potential $1B+ expansion in cardiovascular/neurodegenerative.
Reliance subsidiary EIG issued a $2M promissory note at 7% interest to LifeSci Global to fund the investment; matures April 2031.
CEO Beyman and director Korman have indirect equity in LifeSci Global and recused from board approval; Korman removed from all board committees.
Company highlights potential Rare Pediatric Disease Priority Review Voucher if Innervate's product is approved, which could be monetized.

item 1.01 item 8.01 item 2.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Reliance Global Group, Inc. incurred loan of up to $2,000,000 with LGG at 7% per annum maturing the fifth anniversary of the effective date of the Promissory Note (April 29, 2031).

Instrument: loan
Principal: up to $2,000,000
Counterparty: LGG
Rate: 7% per annum
Maturity: the fifth anniversary of the effective date of the Promissory Note (April 29, 2031)
Event: incurrence

Exact text from the filing

company (“EIG”) that is a wholly-owned subsidiary of the Company, and LGG entered into a Promissory Note (the “Promissory Note”) in the maximum aggregate principal amount of $2,000,000. The Promissory Note bears interest at 7% per annum, compounded annually and accruing daily. Advances under the Promissory Note may be made by EIG to LGG from time to time at

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Reliance Global Group, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-021123

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.